Kit and method for in vitro directional differentiation of human-derived iPS stem cells into myocardial cells
A technology of cardiomyocytes and kits, applied in the fields of stem cell biology and regenerative medicine, which can solve the problems of high prices, great differences in cell lines, unfavorable large-scale production and application, and achieve high safety effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0038] In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with the accompanying drawings and specific embodiments. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art, and the raw materials used are commercially available items.
[0039] As used herein, the term "induced pluripotent stem cell", often abbreviated as iPS cell, refers to an adult that has been reprogrammed to enter an embryonic stem cell-like state by being forced to express factors important for maintaining the "sternness" of embryonic stem cells cell. Generally, iPS cells are artificially prepared from non-pluripotent cells (such as adult human cells, or terminally differentiated cells), such as fibroblasts, hematopoietic cells, muscle cells, neurons, epidermal cells, etc., by The non-pluripotent cells are introd...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com